| |
Group A patients
|
Group B patients
|
|---|
| |
1
|
2
|
3
|
4
|
5
|
1
|
2
|
3
|
4
|
5
|
|---|
|
Anti-Scl-70 antibodies, U/ml
|
|
Baseline
|
120
|
+a
|
0
|
10.2
|
+a
|
0
|
+a
|
39.1
|
130
|
21.3
|
|
2–3 years
|
32.9
|
0
|
0
|
0
|
390
|
0
|
240
|
31.1
|
106.5
|
0
|
|
4–5 years
|
11.6
|
0
|
0
|
0
|
257
|
0
|
352
|
15.9
|
+a
|
0
|
|
Long term
|
0
|
0b
|
0b
|
0
|
>8b
|
0
|
3.8b
|
>8b
|
250
|
0
|
- Anti-Scl-70 antibodies were measured at pre-transplant period (baseline) and sequentially during follow-up by enzyme-linked immunosorbent assay as described in methods section. Quantified results are expressed in arbitrary units/ml as previously published ([8])
-
aPositive for Anti-Scl-70 antibodies
-
bAnti-Scl-70 antibodies levels measured by BioPlex ANA Screen
